Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Finished Goods (2020 - 2025)

Historic Finished Goods for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $9.3 million.

  • NeuroPace's Finished Goods rose 4759.95% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 4759.95%. This contributed to the annual value of $7.4 million for FY2024, which is 1320.61% up from last year.
  • According to the latest figures from Q3 2025, NeuroPace's Finished Goods is $9.3 million, which was up 4759.95% from $8.5 million recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Finished Goods registered a high of $9.3 million during Q3 2025, and its lowest value of $3.7 million during Q1 2021.
  • For the 5-year period, NeuroPace's Finished Goods averaged around $5.9 million, with its median value being $5.6 million (2023).
  • In the last 5 years, NeuroPace's Finished Goods skyrocketed by 798.62% in 2023 and then soared by 4759.95% in 2025.
  • NeuroPace's Finished Goods (Quarter) stood at $4.7 million in 2021, then rose by 14.01% to $5.4 million in 2022, then rose by 20.96% to $6.5 million in 2023, then grew by 13.21% to $7.4 million in 2024, then grew by 27.07% to $9.3 million in 2025.
  • Its Finished Goods was $9.3 million in Q3 2025, compared to $8.5 million in Q2 2025 and $7.2 million in Q1 2025.